Followers | 19 |
Posts | 2094 |
Boards Moderated | 0 |
Alias Born | 06/12/2017 |
Thursday, March 26, 2020 4:52:09 PM
Recent NBY News
- Form PREM14A - Preliminary proxy statements relating to merger or acquisition • Edgar (US Regulatory) • 09/25/2024 09:17:41 PM
- Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm • PR Newswire (US) • 09/23/2024 01:27:00 PM
- Acumen Health Holdings ("Acumen") to Acquire the Avenova brand from NovaBay Pharmaceuticals • PR Newswire (US) • 09/20/2024 12:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/20/2024 12:08:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 12:08:15 PM
- NovaBay Pharmaceuticals Signs Definitive Agreement to Sell its Avenova Assets • Business Wire • 09/20/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:11:02 PM
- NovaBay Pharmaceuticals Reports Second Quarter 2024 Financial Results • Business Wire • 08/13/2024 08:05:00 PM
- NovaBay Pharmaceuticals to Hold Second Quarter 2024 Conference Call on August 13, 2024 • Business Wire • 08/01/2024 10:50:00 AM
- NovaBay Pharmaceuticals Reports Record Amazon Prime Day Sales • Business Wire • 07/30/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/29/2024 08:25:15 PM
- NovaBay Pharmaceuticals Announces Closing of $3.87 Million Underwritten Public Offering, Including Partial Exercise of Overallotment Option • Business Wire • 07/29/2024 08:05:00 PM
- Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)] • Edgar (US Regulatory) • 07/26/2024 09:19:56 PM
- NovaBay Pharmaceuticals Announces Pricing of $3.5 Million Underwritten Public Offering • Business Wire • 07/26/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/26/2024 04:15:03 AM
- NovaBay Pharmaceuticals Offers 20% Discounts on Avenova Eyecare Products During Amazon Prime Day • Business Wire • 07/16/2024 10:50:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/11/2024 12:50:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 12:45:30 PM
- NovaBay Pharmaceuticals Reports Preliminary Second Quarter 2024 Net Revenue of $2.4 Million • Business Wire • 07/11/2024 10:50:00 AM
- Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses • Edgar (US Regulatory) • 07/10/2024 08:05:39 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 07/10/2024 01:30:17 PM
- NovaBay Pharmaceuticals Supports National Dry Eye Awareness Month with Multiple Avenova Product Promotions • Business Wire • 06/28/2024 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 12:47:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 11:30:13 AM
- NovaBay Pharmaceuticals Plan of Compliance Accepted by the NYSE American • Business Wire • 06/07/2024 10:50:00 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM